Actively Recruiting
Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia
Led by Cairo University · Updated on 2026-04-21
50
Participants Needed
1
Research Sites
19 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the efficacy of sublingual caffeine in reducing recovery time and incidence of postoperative agitation in elderly patients undergoing general anesthesia.
CONDITIONS
Official Title
Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3E�3D 65 years
- Both sexes
- American Society of Anesthesiologists (ASA) physical status II
- Scheduled for elective ophthalmology surgery under general anesthesia
You will not qualify if you...
- History of severe cardiac arrhythmias or uncontrolled hypertension
- ASA III patients
- Known allergy or hypersensitivity to caffeine
- Pre-existing cognitive impairment or dementia
- History of seizures or epilepsy
- History of alcohol or drug abuse
- Chronic use of CNS stimulants or sedatives
- Emergency surgeries
- Prolonged procedures longer than 3 hours
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 12613
Actively Recruiting
Research Team
G
Ghada A Sherif, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here